Scarlet Therapeutics develops a proprietary platform that produces therapeutic red blood cells (tRBC Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2026-06-25 | £101k |
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| KCP NOMINEES LTDCORP | A ORDINARY, B ORDINARY | 736,088 | 19.9% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
20 more shareholders on file , sign up free to see.
Companies with the most similar business descriptions.
Some of these officers hold directorships at other companies. Sign up free to see them.
Capital raised per employee divides the equity SCARLET THERAPEUTICS LIMITED raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. SCARLET THERAPEUTICS LIMITED has 3 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
EACH A ORDINARY SHARE IS ENTITLED TO: 1. ONE VOTE ON A POLL OR WRITTEN RESOLUTION. 2. A PRO RATA SHARE OF DIVIDEND PAYMENTS PARI PASSU WITH ORDINARY SHARES AND B ORDINARY SHARES. 3. ON A RETURN OF CAPITAL (INCLUDING ON A LIQUIDATION OR WINDING UP), THE RIGHT TO RECEIVE (I) FIRSTLY, A PRO RATA SHARE OF 0.01% OF THE A ORDINARY AND ORDINARY SHARES UNTIL THE B ORDINARY SHARES HAVE RECEIVED AN AMOUNT EQUAL TO THE B ORDINARY SHARE SUBSCRIPTION AMOUNT (AS DEFINED IN THE ARTICLES OF ASSOCIATION), (II) SECONDLY, A PRO RATA SHARE OF 99.99% UNTIL THE A ORDINARY SHAREHOLDERS HAVE RECEIVED AN AMOUNT EQUAL TO THE A ORDINARY SHARE SUBSCRIPTION AMOUNT (AS DEFINED IN THE ARTICLES OF ASSOCIATION), (III) THIRDLY, A PRO RATA SHARE OF 0.01% OF THE A ORDINARY AND B ORDINARY SHARES UNTIL THE ORDINARY SHAREHOLDERS HAVE RECEIVED AN AMOUNT EQUAL TO THE ORDINARY SHARE SUBSCRIPTION AMOUNT (AS DEFINED IN THE ARTICLES OF ASSOCIATION), AND (IV) THEREAFTER THE RIGHT TO A PRO RATA SHARE OF ANY REMAINING SURPLUS ASSETS PARI PASSU WITH THE ORDINARY AND B ORDINARY SHARES, PROVIDED ALWAYS THAT THE HOLDERS OF ANY DEFERRED SHARES HAVE FIRST RECEIVED A TOTAL OF £1.00 FOR THE ENTIRE CLASS OF DEFERRED SHARES (AS MORE PARTICULARLY SET OUT IN THE ARTICLES OF ASSOCIATION). 4. NON-REDEEMABLE.
EACH SHARE IS ENTITLED TO: 1. ONE VOTE ON A POLL OR WRITTEN RESOLUTION. 2. A PRO RATA SHARE OF DIVIDEND PAYMENTS PARI PASSU WITH ORDINARY SHARES AND A ORDINARY SHARES. 3. ON A RETURN OF CAPITAL (INCLUDING ON A LIQUIDATION OR WINDING UP), THE RIGHT TO RECEIVE (I) FIRSTLY, A PRO RATA SHARE OF 99.99% UNTIL THE B ORDINARY SHAREHOLDERS HAVE RECEIVED AN AMOUNT EQUAL TO THE B ORDINARY SHARE SUBSCRIPTION AMOUNT (AS DEFINED IN THE ARTICLES OF
EACH SHARE IS ENTITLED TO: 1. ONE VOTE ON A POLL OR WRITTEN RESOLUTION. 2. A PRO RATA SHARE OF DIVIDEND PAYMENTS PARI PASSU WITH A ORDINARY SHARES AND B ORDINARY SHARES. 3. ON A RETURN OF CAPITAL (INCLUDING ON A LIQUIDATION OR WINDING UP), THE RIGHT TO RECEIVE (I) FIRSTLY, A PRO RATA SHARE OF 0.01% OF THE ORDINARY AND A ORDINARY SHARES UNTIL THE B ORDINARY SHARES HAVE RECEIVED AN AMOUNT EQUAL TO THE B ORDINARY SHARE SUBSCRIPTION AMOUNT (AS DEFINED IN THE ARTICLES OF ASSOCIATION), (II) SECONDLY, A PRO RATA SHARE OF 0.01% OF THE
These are the directors and secretaries who have left SCARLET THERAPEUTICS LIMITED. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.